新股消息 | Exegenesis Bio Inc.递表港交所

Core Viewpoint - Exegenesis Bio Inc. has submitted its listing application to the Hong Kong Stock Exchange, with CCB International acting as the sole sponsor, highlighting its innovative AAVarta and SODA technology platforms for developing a diverse and scalable product pipeline [1]. Group 1: Company Overview - Exegenesis Bio Inc. is registered in the Cayman Islands and is focused on biotechnology [2]. - The company is developing core candidate products, including EXG001-307 for SMA type 1, along with two key candidates, EXG102-031 and EXG202 [1]. Group 2: Financial Details - The company has set a nominal value of $0.00001 per share for its stock [2]. - Additional costs associated with the share issuance include a 1.0% brokerage commission, transaction fees from the Securities and Futures Commission, and other exchange-related fees [2].